Temoporfin
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01XD05
CAS registry number (Chemical Abstracts Service)
0122341-38-2
Chemical Formula
C44-H32-N4-O4
Molecular Weight
680
Therapeutic Categories
Antineoplastic agent
Photosensitizing agent, used in photodynamic therapy (PDT)
Chemical Names
3,3',3'',3'''-(7,8-Dihydroporphyrin-5,10,15,20-tetrayl)tetraphenol (WHO)
Phenol, 3,3',3'',3'''-(7,8-dihydro-21H,23H-porphine-5,10,15,20-tetrayl)tetrakis- (USAN)
Foreign Names
- Temoporfinum (Latin)
- Temoporfin (German)
- Temoporfine (French)
- Temoporfina (Spanish)
Generic Names
- Temoporfin (OS: BAN, USAN)
- EF 9 (IS: Scotia)
- HK7 (IS)
- KW 2345 (IS)
- meta-Tetrahydroxyphenyl chlorin (IS)
- mTHPC (IS)
- m-THPC (IS)
Brand Names
- Foscan
Biolitec, Belgium; Biolitec, Denmark; Biolitec, Greece; Biolitec, Lithuania; Biolitec, Poland; Biolitec, Portugal; Biolitec, Romania; biolitec pharma, Germany; Techsphere, Argentina
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
